Jim Caruso

Jim Caruso is an accomplished executive in the biopharmaceutical and medical device sectors, currently serving as President, Chief Executive Officer, and Director at Cellectar Biosciences, Inc. since June 2015. With a focus on oncology, Cellectar's lead product, CLR 131, is advancing through clinical studies. In addition, Jim is a co-founder and executive vice president at Hip Innovation Technology, overseeing the development of innovative medical devices. Previous roles include Executive Vice President and Chief Commercial Officer at Allos Therapeutics, Senior Vice President of Sales and Marketing at Bone Care International, and various leadership positions at Novartis Pharmaceuticals, BASF Pharma, and Bristol-Myers Squibb. Jim Caruso holds a Bachelor of Science in Finance from the University of Nevada, Reno.